قطره انف. التهاب الأنف

The investigators plan to carry out an experimental study on the preventive effect of recombinant human interferon alpha nasal drops on the infection of 2019 new coronavirus in medical staff The investigators plan to carry out an experimental study on the preventive effect of recombinant human interferon alpha nasal drops on the infection of 2019 new coronavirus in medical staff
Understanding the different types of nasal sprays Intranasal corticosteroids for non-allergic rhinitis

Intranasal corticosteroids for non-allergic rhinitis.

19
التهاب الأنف
Layout table for study information Study Type : Interventional Clinical Trial Estimated Enrollment : 2944 participants Allocation: Non-Randomized Intervention Model: Parallel Assignment Masking: None Open Label Primary Purpose: Prevention Official Title: An Clinic Trial of Recombinant Human Interferon Alpha Nasal Drops to Prevent Coronavirus Disease 2019 in Medical Staff in Epidemic Area Actual Study Start Date : January 21, 2020 Estimated Primary Completion Date : May 2020 Estimated Study Completion Date : June 2020 Information from the National Library of Medicine Choosing to participate in a study is an important personal decision
أوتريڤين ٠٫١٪ نقط للأنف
The American Academy of Otolaryngic Allergy
إدمان بخاخات الأنف: هل هو حقيقة؟
Drug, brains, and behavior: The science of addiction
The American Academy of Otolaryngic Allergy For general information, Layout table for additonal information Responsible Party: Zhongji Meng, Chief of Infectious disease department, Principal Investigator, Clinical Professor, Shanghai Jiao Tong University School of Medicine ClinicalTrials
Drug, brains, and behavior: The science of addiction

Layout table for study information Study Type : Interventional Clinical Trial Estimated Enrollment : 2944 participants Allocation: Non-Randomized Intervention Model: Parallel Assignment Masking: None Open Label Primary Purpose: Prevention Official Title: An Clinic Trial of Recombinant Human Interferon Alpha Nasal Drops to Prevent Coronavirus Disease 2019 in Medical Staff in Epidemic Area Actual Study Start Date : January 21, 2020 Estimated Primary Completion Date : May 2020 Estimated Study Completion Date : June 2020 Information from the National Library of Medicine Choosing to participate in a study is an important personal decision.

أوتريڤين ٠٫١٪ نقط للأنف
To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below
أوتريڤين ٠٫١٪ نقط للأنف
To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below
التهاب الأنف
For general information, Layout table for additonal information Responsible Party: Zhongji Meng, Chief of Infectious disease department, Principal Investigator, Clinical Professor, Shanghai Jiao Tong University School of Medicine ClinicalTrials
FDA-regulated Drug Product: No Studies a U FDA-regulated Drug Product: No Studies a U
Cochrane Database of Systematic Reviews FDA-regulated Device Product: No Layout table for MeSH terms Coronavirus Infections Coronaviridae Infections Nidovirales Infections RNA Virus Infections Virus Diseases Interferons Interferon-alpha Thymalfasin Antineoplastic Agents Antiviral Agents Anti-Infective Agents Immunologic Factors Physiological Effects of Drugs Adjuvants, Immunologic

Understanding the different types of nasal sprays.

22
أوتريڤين ٠٫١٪ نقط للأنف
Talk with your doctor and family members or friends about deciding to join a study
Experimental Trial of rhIFNα Nasal Drops to Prevent 2019
Talk with your doctor and family members or friends about deciding to join a study
بخاخ أنفي
Cochrane Database of Systematic Reviews